Etaracizumab

Tax included
Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer.
MedChemExpress 
HY-P99291

Data sheet

Size
Multiple sizes
Reactivity
Integrin
Application
Cancer-programmed cell death
CAS
892553-42-3